Tags: Drug.

JWH-193 is a drug from the aminoalkylindole family which acts as a cannabinoid receptor agonist. It was invented by the pharmaceutical company Sanofi-Winthrop in the early 1990s. JWH-193 has a binding affinity at the CB1 receptor of 6nM binding around seven times more tightly than the parent compound JWH-200 though with closer to twice the potency of JWH-200 in activity tests.

JWH-193_structure.png
CAS number
133438-58-1
IUPAC name
(1-(2-morpholin-4-ylethyl)indol-3-yl)-4-methylnaphthalen-1-ylmethanone
PubChem
10250276

Loading...

This page contains content from the copyrighted Wikipedia article "JWH-193"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.